LivaNova (LIVN) Competitors $47.59 +0.10 (+0.21%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LIVN vs. PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, NVST, NARI, and IRTCShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. LivaNova vs. Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends. Do analysts rate PEN or LIVN? Penumbra currently has a consensus price target of $258.00, suggesting a potential upside of 6.37%. LivaNova has a consensus price target of $69.17, suggesting a potential upside of 45.34%. Given LivaNova's stronger consensus rating and higher probable upside, analysts plainly believe LivaNova is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80LivaNova 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media prefer PEN or LIVN? In the previous week, Penumbra had 7 more articles in the media than LivaNova. MarketBeat recorded 14 mentions for Penumbra and 7 mentions for LivaNova. LivaNova's average media sentiment score of 0.99 beat Penumbra's score of 0.86 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PEN or LIVN more profitable? Penumbra has a net margin of 2.97% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra2.97% 8.99% 6.80% LivaNova 1.91%13.81%7.07% Which has more risk and volatility, PEN or LIVN? Penumbra has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Does the MarketBeat Community favor PEN or LIVN? Penumbra received 426 more outperform votes than LivaNova when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 69.31% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformPenumbraOutperform Votes81980.29% Underperform Votes20119.71%LivaNovaOutperform Votes39369.31% Underperform Votes17430.69% Which has stronger valuation and earnings, PEN or LIVN? Penumbra has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.16B8.00$90.95M$0.86282.02LivaNova$1.24B2.08$17.55M$0.42113.31 Do insiders and institutionals hold more shares of PEN or LIVN? 88.9% of Penumbra shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 5.0% of Penumbra shares are owned by insiders. Comparatively, 0.3% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryPenumbra beats LivaNova on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.58B$3.01B$5.10B$9.07BDividend YieldN/A1.75%4.90%4.21%P/E Ratio113.3116.1591.0817.15Price / Sales2.0850.151,113.51116.81Price / Cash11.9639.9142.2637.86Price / Book2.013.724.784.78Net Income$17.55M$89.83M$119.77M$225.60M7 Day Performance-7.59%-1.82%-1.87%-1.23%1 Month Performance-7.95%0.28%11.46%3.07%1 Year Performance-8.16%4.10%30.53%16.48% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.6278 of 5 stars$47.59+0.2%$69.17+45.3%-4.4%$2.58B$1.24B113.312,900Analyst UpgradePositive NewsHigh Trading VolumePENPenumbra4.225 of 5 stars$248.21+1.1%$252.42+1.7%-1.8%$9.53B$1.16B285.524,200Analyst ForecastGKOSGlaukos4.1194 of 5 stars$143.87+3.6%$143.17-0.5%+89.5%$7.93B$360.35M-46.00780Analyst ForecastShort Interest ↓BLCOBausch + Lomb3.1618 of 5 stars$18.60flat$20.58+10.7%+16.9%$6.55B$4.68B-17.7113,300INSPInspire Medical Systems4.6583 of 5 stars$187.95+0.1%$233.58+24.3%+1.7%$5.63B$755.59M176.781,011Positive NewsPRCTPROCEPT BioRobotics2.7661 of 5 stars$89.09-0.2%$97.86+9.8%+102.9%$4.65B$136.19M0.00626Positive NewsAXNXAxonics1.4263 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.4937 of 5 stars$32.75-2.0%$32.67-0.3%+138.4%$3.54B$577.74M-23.861,453NVSTEnvista3.9074 of 5 stars$19.59+0.6%$20.65+5.4%-21.1%$3.37B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3112 of 5 stars$55.39-0.4%$58.89+6.3%-11.9%$3.24B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.0873 of 5 stars$89.50+3.6%$107.82+20.5%-14.3%$2.80B$492.68M-17.782,000Analyst Forecast Related Companies and Tools Related Companies PEN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives PRCT Alternatives AXNX Alternatives NVCR Alternatives NVST Alternatives NARI Alternatives IRTC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIVN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIVN Stock Alerts